These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32002597)

  • 21. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs.
    Cao Y; Li D; Fu Y; Bai Q; Chen Y; Bai X; Jing Z; Sun P; Bao H; Li P; Zhang J; Ma X; Lu Z; Liu Z
    Antiviral Res; 2017 Apr; 140():133-141. PubMed ID: 28161579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
    De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
    Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of novel inactivated vaccine for type C foot-and-mouth disease in cattle and pigs.
    You SH; Jo HE; Choi JH; Ko MK; Shin SH; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2019 Jul; 234():44-50. PubMed ID: 31213271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
    Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
    Fowler VL; Knowles NJ; Paton DJ; Barnett PV
    Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
    Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
    Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z; Pan L; Ding Y; Zhou P; Lv J; Chen H; Fang Y; Liu X; Chang H; Zhang J; Shao J; Lin T; Zhao F; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1389-98. PubMed ID: 25381487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunity Evaluation of an Experimental Designed Nanoliposomal Vaccine Containing FMDV Immunodominant Peptides.
    Heshmati L; Rezayat SM; Madani R; Emami T; Jafari MR; Golchinfar F; Kazemi M; Azimi Dezfouli SM
    Arch Razi Inst; 2021 Nov; 76(5):1183-1190. PubMed ID: 35355777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.
    Li P; Bai X; Sun P; Li D; Lu Z; Cao Y; Fu Y; Bao H; Chen Y; Xie B; Liu Z
    BMC Vet Res; 2012 May; 8():57. PubMed ID: 22591597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single amino acid substitution in the VP2 protein of Indian foot-and-mouth disease virus serotype O vaccine strain confers thermostability and protective immunity in cattle.
    Biswal JK; Sreenivasa BP; Mohapatra JK; Subramaniam S; Jumanal V; Basagoudanavar SH; Dhanesh VV; Hosamani M; Tamil Selvan RP; Krishnaswamy N; Ranjan R; Pattnaik B; Singh RK; Mishra BP; Sanyal A
    Transbound Emerg Dis; 2022 Nov; 69(6):3651-3663. PubMed ID: 36219528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
    Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.
    Pega J; Di Giacomo S; Bucafusco D; Schammas JM; Malacari D; Barrionuevo F; Capozzo AV; Rodríguez LL; Borca MV; Pérez-Filgueira M
    J Virol; 2015 Sep; 89(18):9581-90. PubMed ID: 26157128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity of foot-and-mouth disease serotype Asia 1 by sublingual vaccination.
    Chen HT; Liu YS
    PLoS One; 2013; 8(5):e63839. PubMed ID: 23717497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Protective Immunity against Inactivated Iranian Isolate of Foot-and-Mouth Disease Virus Type O/IRN/2007 Using Gamma Ray-Irradiated Vaccine on BALB/c Mice and Guinea Pigs.
    Motamedi-Sedeh F; Soleimanjahi H; Jalilian AR; Mahravani H; Shafaee K; Sotoodeh M; Taherkarami H; Jairani F
    Intervirology; 2015; 58(3):190-6. PubMed ID: 26202581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage.
    Waters R; Ludi AB; Fowler VL; Wilsden G; Browning C; Gubbins S; Statham B; Bin-Tarif A; Mioulet V; King DJ; Colenutt C; Brown E; Hudelet P; King DP
    Vaccine; 2018 Mar; 36(14):1901-1907. PubMed ID: 29506922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.